A wrong product call in most industries costs a quarter. In US financial services it can cost restitution, a consent order, and an examiner's attention. Weaxen brings depth to the evidence, rigour to the sign-off, and eyes on the outcome after launch β so the decision holds up the first time, and keeps holding up.
UDAAP gives the CFPB and prudential regulators broad authority to ask whether a product causes consumer harm β especially products that combine features in ways that obscure cost or risk. Examiners expect new products reviewed for that harm up front, with the analysis to show for it. A confident slide isn't that analysis.
SR 11-7 doesn't stop at building a sound model β it requires outcomes analysis and ongoing monitoring that triggers review when performance drifts. That discipline increasingly reaches any product making automated decisions, and most teams have no structured way to sustain it after launch.
A change to a lending decision and a tweak to a marketing page should not clear the same committee β but teams either drown every idea in the same heavy review, or wave things through with none. The rigour is rarely matched to the actual risk of the decision.
Teams describe what they're building in plain language. No taxonomy to learn, no template to fill.
Path Forger recommends the right artefacts for your stage and risk level. A scrappy pre-seed run looks different to a Series A launch β same engine, right dose.
Every decision documented. Every assumption surfaced. Every risk traceable. Ready for engineers, boards, or Claude Code.
Weaxen holds your product research and decision records β not your customers' financial data. Your workspace content is encrypted in transit and at rest, and where residency is required we hold it in-region, including on US soil.
Yes. Role-based access within organisations, MFA, and β on enterprise agreements β SAML single sign-on with DNS-verified domains and optional SSO enforcement, backed by an organisation-level audit log.
Weaxen is built around exactly what examiners ask for: who decided, on what evidence, with whose sign-off, and how the product is performing now. Every artefact is versioned; nothing depends on someone remembering.
Bring one live initiative β ideally one heading for a product-approval or model-risk committee β and run it through the framework. You'll see the review pack assemble itself within days.
For teams who treat "build the right thing" as a precondition, not a slogan. Start for free β